TMS THERAPY
FDA-cleared, non-medication depression treatment
(855) 940-4867
Greenbrook now offers Spravato®, the
only FDA-approved
ketamine-based psychedelic treatment for
depression.
What is Spravato® ?
Spravato® is an FDA-approved nasal esketamine spray, a more specific form of ketamine designed to treat depression. Ketamine is a drug that's primarily known for its uses as an anesthetic. You may have also heard of ketamine being used as a psychedelic street drug, but if it's used under the supervision of a doctor, it can be perfectly safe.
Spravato® was FDA-approved in 2019 for people with depression who have not experienced adequate improvement with antidepressant medications.
Coverage is key
Many major insurance companies cover esketamine nasal spray for depression.
A benefit of having treatment at a Greenbrook center is that our Care Team does all the work for you regarding insurance. We assist all patients with the coverage and reimbursement process.
How does it feel?
During a Spravato® treatment, you may feel dizzy, or euphoric. Throughout your treatment, our Care Team will be onsite to assist you.
After your two-hour session, you may be groggy and woozy. You will need to avoid hazardous activity for the remainder of the day. This includes operating a motor vehicle, so you will need someone to drive you home from treatment. By the next morning, most people are ready to resume their day with no restrictions.
Where can I be treated?
We offer Spravato® esketamine nasal spray for depression at select Greenbrook centers.
Spravato® must be given at a certified REMS (Risk Evaluation and Mitigation System) center. The medical staff at Greenbrook's certified treatment centers are trained to prescribe, dispense, and administer Spravato®, and we have established processes and procedures in accordance with the REMS program.
You will first talk with one of our intake specialists, who will collect some basic information and arrange a meeting with one of our Consult Coordinators. The Consult Coordinator can meet with you in person, over video conference, or on the phone and will review your history and explain aspects of esketamine nasal spray treatment.
Your Consult Coordinator will also explain treatment payment options and review standard insurance plan criteria with you. We will coordinate with your health insurance provider to determine benefits.
IS SPRAVATO® COVERED BY INSURANCE?
Yes! Many major insurance companies cover ketamine-based depression treatment if you haven't gotten better after trying just TWO antidepressants.
SHOULD I RECEIVE IV KETAMINE OR SPRAVATO® (NASAL ESKETAMINE)?
IV ketamine
Esketamine nasal spray (Spravato®)
Next, you will meet with a Greenbrook affiliated provider for an evaluation, which includes questions about your history and symptoms.
If the Greenbrook provider has determined that you are a candidate for esketamine nasal spray and you are ready to move forward, they will create your individualized treatment plan.
At most Greenbrook centers, we try to book your Spravato® treatments to accommodate your schedule, whether morning or afternoon appointments work best for you.
After you arrive at the center, you will be placed in a reclining chair where you can sit back and relax. You will be handed a nasal spray device to self-administer. Your care team will supervise you for at least two hours. Afterward, you will need someone to drive you home from treatment. By the next morning, most people are ready to resume their day with no restrictions.
TYPICAL SPRAVATO®
TREATMENT SESSION
Find out if Greenbrook can help you or a loved one
Treatment varies by individual. Some patients complete maintenance after the initial induction plan.
Week 1-4
2 treatments a week
Week 5-8
1 treatment a week
Week 9+
1 treatment every 1-2 weeks
Because Spravato® is a ketamine-based treatment for depression, during treatment, you may feel dizzy or euphoric. Our Care Team will be there to assist you throughout your treatment. Your blood pressure will be checked upon arrival, 40 minutes in, and before you leave.
After your two-hour treatment, you may be groggy and woozy. You will need to avoid hazardous activity for the remainder of the day, including operating a motor vehicle, so you will need someone to drive you home from treatment.
Your Consult Coordinator will help you find out if Spravato® is right for you!
Please provide the requested information on the form and Greenbrook TMS will contact you shortly. All information will be kept strictly confidential. We do not sell or share your information.
Spravato® is nasal esketamine, a more specific form of ketamine designed to treat depression.
Spravato® takes the effective part of ketamine and isolates that and then gets rid of the sedating part of ketamine that is not believed to be as important for depression.
Spravato® esketamine nasal spray is FDA-approved for people with depression who have not experienced adequate improvement with antidepressant medications.
A typical round of esketamine nasal spray treatment is broken up into three phases:
Treatment plan varies by individual. Some patients complete maintenance after the initial induction plan.
Before each appointment, avoid eating for two hours and drinking large amounts of fluid for 30 minutes.
Each session takes place at a private, spa-like Greenbrook center. Once you arrive, you'll sit in a comfortable recliner, and a technician will check your blood pressure. You will then complete a short form, after which you will be handed a nasal spray device to self-administer. We will go over how to administer the spray to yourself.
Throughout your treatment, our care team will be onsite to assist you. Your blood pressure is checked at the start of the session, 40 minutes into treatment, and before you leave the Greenbrook center. You must stay in the center for at least two hours. Ensure you have someone to drive you home, as you will not be able to operate a motor vehicle for the rest of the day.
Your Greenbrook provider will determine the dose of Spravato® based on your treatment plan. There will be 2-3 sprays self-administered in each nostril, depending on the dose prescribed by your provider.
That's okay! Our Consult Coordinators will help you decide if Spravato® depression treatment is right for you. If it isn't, Greenbrook also offers TMS therapy, which is a non-drug, non-sedating FDA-cleared treatment for depression. You can learn more about TMS by asking your Consult Coordinator or taking our TMS quiz.
Yes. You must be on an antidepressant medication to receive Spravato® treatment.
No. Nasal esketamine must be given at a certified REMS (risk evaluation and mitigation system) center, such as a convenient outpatient Greenbrook TMS center.
The medical staff at Greenbrook’s certified treatment centers are trained to prescribe, dispense, and administer Spravato®, and we have established processes and procedures in accordance with the REMS program.
No. Esketamine nasal spray is FDA-approved for people with depression who have not experienced adequate improvement with antidepressant medications.
Greenbrook TMS recommends calling for more information on whether treatment is right for you. Below are some of the common contraindications, but each patient's journey is unique.
Yes! Many major insurance companies cover Spravato® depression treatment if you haven’t gotten better after trying two oral antidepressants.
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.